Navigation Links
Alexza Pharmaceuticals Reports 2010 Third Quarter Financial Results and Provides Business Update
Date:11/9/2010

w.alexza.com/about/the-staccato-system/staccato-animation">here to see an animation of how the Staccato system works.)

AZ-004 (Staccato loxapine) is Alexza's lead program, which is being developed for the rapid treatment of agitation in schizophrenic or bipolar disorder patients. Alexza has completed and announced positive results from both of its AZ-004 Phase 3 clinical trials and submitted a New Drug Application (NDA) in December 2009.  In October 2010, the Company received a CRL from the FDA, regarding its NDA for AZ-004.  A CRL is issued by FDA's Center for Drug Evaluation and Research indicating that the NDA review cycle is complete and the application is not ready for approval in its present form.  The Company is currently evaluating the FDA's comments in the CRL and anticipates meeting with the FDA in the fourth quarter of 2010 to discuss the CRL.

For more information about Alexza, the Staccato technology or the Company's development programs, please visit www.alexza.com.

Safe Harbor Statement

Alexza's policy is to only provide guidance on product candidates and corporate goals for the future one to two fiscal quarters, and to provide, update or reconfirm its guidance only by issuing a press release or filing updated guidance with the SEC in a publicly accessible document.  The Company's guidance in this release is as of November 9, 2010 and financial guidance relating to the Company's current cash, cash equivalents and investments is as of September 30, 2010.

This news release contains forward-looking statements that involve significant risks and uncertainties, including our ability to establish a path for AZ-004 approval after meeting with the FDA. Any statement describing the Company's expectations or beliefs is a forward-looking statement, as defined in the Private Securities Litigation Reform Act of 1995, and should be co
'/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Alexza Completes Target Enrollment in AZ-104 Phase 2a Clinical Trial in Migraine Patients
2. Alexza Initiates AZ-007 (Staccato(R) Zaleplon) Phase 1 Clinical Trial and Updates Clinical Pipeline Development Status
3. Alexzas AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache
4. Alexza Reports 2007 Year-End Financial Results and Updates Clinical Pipeline Status
5. Alexza Announces Positive Phase 1 Results With AZ-007 (Staccato(R) Zaleplon)
6. Alexza Completes Enrollment in Phase 2a Clinical Trial With AZ-002 (Staccato(R) Alprazolam) in Panic Disorder Patients
7. Alexza Pharmaceuticals to Present AZ-004 Phase 2a Clinical Data at the American Psychiatric Association Annual Meeting
8. Alexza Announces Preliminary Results From its AZ-002 (Staccato(R) Alprazolam) Phase 2a Proof-of-Concept Trial in Patients With Panic Disorder
9. Alexza Completes Enrollment in Phase 3 Clinical Trial with AZ-004 (Staccato(R) Loxapine) for Acute Agitation
10. Alexza Pharmaceuticals to Present AZ-104 Phase 2a Clinical Data at the American Headache Society Annual Scientific Meeting
11. Alexza Initiates Second Phase 3 Clinical Trial for AZ-004 (Staccato(R) Loxapine)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... British Columbia and MENLO PARK, ... Pharmaceuticals, Inc. (OTCQX: DMPI) ("DelMar" and the "Company"), ... of new cancer therapies, today announced its financial results ... provided an overview of recent Company highlights and expected ... host a business update conference call and live webcast ...
(Date:9/3/2015)... 3, 2015 Report Details ... that Market, its R&D and Sales Potentials ... of cancer-treating medicines? Visiongain,s new report gives you revenue predictions ... you discover financial data, R&D trends, opportunities, interviews and revenue ... analysis you see forecasted sales to 2025 at overall world ...
(Date:9/3/2015)... About cardiovascular implants ... or blockage of blood vessels. Cardiac disease is ... cholesterol, and high blood pressure. Coronary artery disease, ... failure are some of the major cardiac diseases. ... coronary arteries, is one of the most common ...
Breaking Medicine Technology:DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 2DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 3DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 4DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 5DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 6DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 7DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 8World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 2World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 3World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 4World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 5World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 6World Cancer-Treating Drugs Industry and Market: Companies, Therapies, R&D and Forecasts 2015-2025 7Global Cardiovascular Implants Market 2015-2019 2
(Date:9/4/2015)... ... ... Having access to a doctor can sometimes be a challenge for a ... room visits which affects hospitals’ abilities to provide quality service to those with serious ... alleviate this problem has recently presented itself, the new telemedicine platform and app, ...
(Date:9/4/2015)... York, NY (PRWEB) , ... September 04, 2015 , ... ... meters qualifying heat, and followed up with victory in the men’s 400 meters final, ... (NACAC) Senior Track and Field Championships in San Jose, Costa Rica in August 2015. ...
(Date:9/4/2015)... ... September 04, 2015 , ... Compliance ... to settlements under the Stark physician self-referral law. “Stark Law DOs and ... from Atlantic Information Services, Inc. (AIS), will detail which deals are attracting the ...
(Date:9/4/2015)... ... September 04, 2015 , ... ... Labor Day offer that cannot be passed up. FiltersFast.com, will ship all ... air and water filtration product replacements. Take advantage of this promotion now through ...
(Date:9/4/2015)... ... September 04, 2015 , ... Friday night, Chicago lovebirds Jenny McCarthy and ... Night of Hope event supporting families affected by autism, raising nearly $250,000. , ... joined together at the Oscar Swan Inn to support the cause. , McCarthy ...
Breaking Medicine News(10 mins):Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 2Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 3Health News:Lalonde Gordon’s Recipe Brings Home the Gold 2Health News:Lalonde Gordon’s Recipe Brings Home the Gold 3Health News:Sept. 17 Webinar to Offer Best Practices for Physician Contracts 2Health News:FiltersFast.com Wows with a Long Labor Day Weekend Shipping Offer 2Health News:Jenny McCarthy & Donnie Wahlberg Help Raise Over $200,000 For Generation Rescue’s ‘Night Of Hope’ Chicago Charity Event 2
... feel young, but often ignore important, health issues; company teams with ... ... LOUIS, Jan. 31 Baby boomers are living,longer and leading more active ... to long-term health. According to a,recent survey by Energizer Holdings, Inc. (NYSE: ...
... a Greater, Concentration of Antioxidants than Other Fruit and ... Health Benefits ... According to the,American Heart Association, cardiovascular disease remains the number ... today. Now, a,recent review of scientific research suggests cranberries may ...
... in Evolving Field of Protein Homeostasis -, ... MLNM ) and Harvard Medical School,s Office ... pursue a research program in the area of ... biology. Under the terms of the,agreement, Harvard has ...
... Patients treated at top-rated hospitals nationwide are nearly ... those admitted to all other hospitals, according to ... independent healthcare ratings organization. Patients who undergo surgery ... five percent lower risk of complications during their ...
... identified a potential new mechanism through which human T-lymphotropic ... published this week in the online open access journal ... histone protein levels has been linked to viral infection ... a retrovirus that causes adult T-cell leukaemia/lymphoma (ATLL). A ...
... have time to build to dangerous levels in body ... 30 (HealthDay News) -- The latest chapter in the ... written Wednesday with release of a study that showed ... babies, bodies and can,t build up to toxic levels. ...
Cached Medicine News:Health News:Boomers: Feeling Young or Fooling Themselves? 2Health News:Boomers: Feeling Young or Fooling Themselves? 3Health News:Boomers: Feeling Young or Fooling Themselves? 4Health News:Tufts University Review Finds Cranberries Support a Healthy Heart 2Health News:Millennium and Harvard Medical School Sign Cooperative Agreement for Research in Novel Field of Cancer Biology 2Health News:Millennium and Harvard Medical School Sign Cooperative Agreement for Research in Novel Field of Cancer Biology 3Health News:Millennium and Harvard Medical School Sign Cooperative Agreement for Research in Novel Field of Cancer Biology 4Health News:Millennium and Harvard Medical School Sign Cooperative Agreement for Research in Novel Field of Cancer Biology 5Health News:Millennium and Harvard Medical School Sign Cooperative Agreement for Research in Novel Field of Cancer Biology 6Health News:Top hospitals have 27 percent lower mortality, annual HealthGrades study finds 2Health News:Top hospitals have 27 percent lower mortality, annual HealthGrades study finds 3Health News:Mercury in Childhood Vaccines Excreted Quickly 2Health News:Mercury in Childhood Vaccines Excreted Quickly 3Health News:Mercury in Childhood Vaccines Excreted Quickly 4
... Vikingselect Intra-Operative Monitoring (IOM). Minimize ... brain and nervous system. Time-stamped event ... amplitudes. Quick visual overview of the ... on-line. Special software allows simultaneous frequency ...
... Endeavor is a neuromonitoring system especially ... monitoring. Endeavor amplifier has 16 channels and ... active electrode inputs. Each channel can be ... or a true differential channel. Endeavor amplifiers ...
... - innovative diabetes management software - ... This quality improvement tool helps ... outcomes. DiaTrends bridges medicine with ... user-friendly diabetes management information technology product. ...
... Managing diabetes requires making decisions about ... about exercise. These decisions are guided by ... relevant information, and by the patterns that ... Health Care Providers when the data is ...
Medicine Products: